WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-25·Latest →

General Motors (GM) Stock Analysis

OW

GM Equity Research — OVERWEIGHT — June 2026

← BKNGHD →

Rating date

Jun 25, 2026

46 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

40p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · GM

Now I have all the information needed. Here is the analysis.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • GM is in a well-established long-term uptrend, up ~65% over the past year, with the 200-day SMA sloping upward and providing structural support near $74.45.
  • Short-term momentum has decisively turned negative. The MACD bearish crossover, declining RSI (now below 50), and price slipping under the 50-day SMA all point to ongoing weakness in the near term.
  • The stock is in a corrective pullback from its May–June highs (~$85). The failure of the June 22 bounce to regain the Bollinger Band middle (~$81.48) suggests sellers remain in control.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

GM Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

32 min read

WebserviceX · Agentic Research Desk

GM Equity Research Note

Published Jun 25, 2026 · Desk view OVERWEIGHT · Generated 2026-06-26T07:58:20Z · Maintained by Walter Vijayakumar · Methodology · Track record

GM Stock Rating Summary

GM bias

OVERWEIGHT

Horizon

Short to medium term

GM key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

GM catalyst watch

GM is in a well-established long-term uptrend, up ~65% over the past year, with the 200-day SMA sloping upward and providing structural support near $74.45.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 40p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:14.554853+00:00.

5D move

—

2026-06-25 → awaiting

Outcome

Awaiting market data

5D trend

-1.32%

Vol (20D ann.)

+30.40%

vs SPY: -0.68%

Close 78.53 → — (USD, vendor closes)

Batch scorecard · 2026-06-25 · GM

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 3dde97d5…

No QC issues recorded.